Site-Directed Mutagenesis of the SH2- and SH3-Coding Domains of c-src Produces Varied Phenotypes, Including Oncogenic Activation of p60^c-src

Literature Cited

• Brugge, J. S., and D. Darrow. 1984. Analysis of the catalytic domain of phosphotransferase activity of two avian sarcoma virus-transforming proteins. J. Biol. Chem. 259:4550–4557.
   PubMedGoogle Scholar
• Bryant, D., and J. T. Parsons. 1982. Site-directed mutagenesis of the src gene of Rous sarcoma virus: construction and characterization of a deletion mutant temperature sensitive for transformation. J. Virol. 44:683–691.
   PubMedGoogle Scholar
• Cartwright, C. A., W. Eckhart, S. Simon, and P. L. Kaplan. 1987. Cell transformation by pp60c-src mutated in the carboxyterminal regulatory domain. Cell 49:83–91.
   PubMed Web of Science ®Google Scholar
• Cooper, J. A., F. S. Esch, S. S. Taylor, and T. Hunter. 1984. Phosphorylation sites in enolase and lactate dehydrogenase utilized by tyrosine kinases in vivo and in vitro. J. Biol. Chem. 259:7835–7841.
   PubMed Web of Science ®Google Scholar
• Cooper, J. A., K. L. Gould, C. A. Cartwright, and T. Hunter. 1986. Tyr 527 is phosphorylated in pp60c-src: implications for regulation. Science 231:1431–1434.
   PubMed Web of Science ®Google Scholar
• Courtneidge, S. A. 1985. Activation of the pp60c-src kinase by middle T antigen binding or by dephosphorylation. EMBO J. 4:1471–1477.
   PubMedGoogle Scholar
• Cross, F. R., E. A. Garber, and H. Hanafusa. 1985. N-terminal deletions in Rous sarcoma virus p60src: effects on tyrosine kinase and biological activities and on recombination in tissue culture with the cellular src gene. Mol. Cell. Biol. 5:2789–2795.
   PubMedGoogle Scholar
• Cross, F. R., E. A. Garber, D. Pellman, and H. Hanafusa. 1984. A short sequence in the p60src N terminus is required for p60src myristylation and membrane association and for cell transformation. Mol. Cell. Biol. 4:1834–1842.
   PubMed Web of Science ®Google Scholar
• DeClue, J. E., and G. S. Martin. 1989. Linker insertion-deletion mutagenesis of the v-src gene: isolation of host- and temperature-dependent mutants. J. Virol. 63:542–554.
   PubMed Web of Science ®Google Scholar
• DeClue, J. E., I. Sadowski, G. S. Martin, and T. Pawson. A conserved domain regulates interactions of the v-fps proteintyrosine kinase with the host cell. Proc. Natl. Acad. Sci. USA 84:9064–9068.
   Google Scholar
• Franz, W. M., P. Berger, and J. Y. J. Wang. 1989. Deletion of an N-terminal regulatory domain of the c-abl tyrosine kinase activates its oncogenic potential. EMBO J. 8:137–147.
   PubMed Web of Science ®Google Scholar
• Garber, E. A., F. R. Cross, and H. Hanafusa. 1985. Processing of p60v-src to its myristylated membrane-bounded form. Mol. Cell. Biol. 5:2781–2788.
   PubMedGoogle Scholar
• Garber, E. A., J. A. Krueger, H. Hanafusa, and A. R. Goldberg. 1983. Only membrane-associated RSV src proteins have amino- terminally bound lipid. Nature (London) 302:161–163.
   PubMed Web of Science ®Google Scholar
• Graham, F. L., and A. J. Van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456–467.
   PubMed Web of Science ®Google Scholar
• Henkemeyer, M. J., R. L. Bennett, F. B. Gertler, and F. M. Hoffmann. 1988. DNA sequence, structure, and tyrosine kinase activity of the Drosophila melanogaster Abelson proto-oncogene homolog. Mol. Cell. Biol. 8:843–853.
   PubMed Web of Science ®Google Scholar
• Hoffmann, F. M., L. D. Fresco, H. Hoffman-Falk, and B.-Z. Silo. 1983. Nucleotide sequences of the Drosophila src and abl homologs: conservation and variability in the src family oncogenes. Cell 35:393–401.
   PubMedGoogle Scholar
• Houts, G. E., M. Miyagi, C. Ellis, D. Beard, and J. W. Beard. 1979. Reverse transcriptase from avian myeloblastosis virus. J. Virol. 29:517–522.
   PubMedGoogle Scholar
• Hughes, S. H., J. J. Greenhouse, C. J. Petropoulos, and P. Sutrave. 1987. Adaptor plasmids simplify the insertion of foreign DNA into helper-independent retroviral vectors. J. Virol. 61:3004–3012.
   PubMed Web of Science ®Google Scholar
• Hunter, T., and J. A. Cooper. 1985. Protein-tyrosine kinases. Annu. Rev. Biochem. 54:897–930.
   PubMed Web of Science ®Google Scholar
• Jackson, P., and D. Baltimore. 1989. N-terminal mutations activate the leukemogenic potential of the myristoylated form of c-abl. EMBO J. 8:449–456.
   PubMed Web of Science ®Google Scholar
• Jove, R., and H. Hanafusa. 1987. Cell transformation by the viral src oncogenes. Annu. Rev. Cell Biol. 3:31–56.
   PubMedGoogle Scholar
• Jove, R., B. J. Mayer, H. Iba, D. Laugier, F. Poirier, G. Calothy, T. Hanafusa, and H. Hanafusa. 1986. Genetic analysis of p60v-src domains involved in the induction of different cell transformation parameters. J. Virol. 60:840–848.
   PubMedGoogle Scholar
• Kamps, M. P., J. E. Buss, and B. M. Sefton. 1986. Rous sarcoma virus transforming protein lacking myristic acid phosphorylates known polypeptide substrates without inducing transformation. Cell 45:105–112.
   PubMedGoogle Scholar
• Kaplan, J. M., G. Mardon, J. M. Bishop, and H. E. Varmus. 1988. The first seven amino acids encoded by the v-src oncogene act as a myristylation signal: lysine 7 is a critical determinant. Mol. Cell. Biol. 8:2435–2441.
   PubMed Web of Science ®Google Scholar
• Kato, J.-Y., T. Takeya, C. Grandori, H. Iba, J. B. Levy, and H. Hanafusa. 1986. Amino acid substitutions sufficient to convert the nontransforming p60c-src protein to a transforming protein. Mol. Cell. Biol. 6:4155–4160.
   PubMed Web of Science ®Google Scholar
• Keating, M. T., and L. T. Williams. 1987. Processing of the platelet-derived growth factor receptor. J. Biol. Chem. 262:7932–7937.
   PubMed Web of Science ®Google Scholar
• Kitamura, N., and M. Yoshida. 1983. Small deletion in src of Rous sarcoma virus modifying transforming phenotypes: identification of 207-nucleotide deletion and its smaller product with protein kinase activity. J. Virol. 46:985–992.
   PubMedGoogle Scholar
• Kmiecik, T. E., and D. Shalloway. 1987. Activation and suppression of pp60c-src transforming ability by mutation of its primary sites of tyrosine phosphorylation. Cell 49:65–73.
   PubMed Web of Science ®Google Scholar
• Kunkel, T. A. 1985. Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc. Natl. Acad. Sci. USA 82:488–492.
   PubMed Web of Science ®Google Scholar
• Levinson, A. D., S. A. Courtneidge, and J. M. Bishop. 1981. Structural and functional domains of the Rous sarcoma virus transforming protein (pp60src). Proc. Natl. Acad. Sci. USA 78:1624–1628.
   PubMed Web of Science ®Google Scholar
• Levy, J. B., H. Iba, and H. Hanafusa. 1986. Activation of the transforming potential of p60c-src by a single amino acid change. Proc. Natl. Acad. Sci. USA 83:4228–4232.
   PubMed Web of Science ®Google Scholar
• Mayer, B. J., M. Hamaguchi, and H. Hanafusa. 1988. A novel viral oncogene with structural similarity to phospholipase C. Nature (London) 332:272–275.
   PubMed Web of Science ®Google Scholar
• Myers, R. M., L. S. Lerman, and T. Maniatis. 1985. A general method for saturation mutagenesis of cloned DNA fragments. Science 229:242–247.
   PubMed Web of Science ®Google Scholar
• Nakamaye, K. L., and F. Eckstein. 1986. Inhibition of restriction endonuclease Neil cleavage by phosphorothioate groups and its application to oligonucleotide-directed mutagenesis. Nucleic Acids Res. 14:9679–9698.
   PubMed Web of Science ®Google Scholar
• Pawson, T. 1988. Non-catalytic domains of cytoplasmic proteintyrosine kinases: regulatory elements in signal transduction. Oncogene 3:491–495.
   PubMed Web of Science ®Google Scholar
• Pellman, D., E. A. Garber, F. R. Cross, and H. Hanafusa. 1985. An N-terminal peptide from p60src can direct myristylation and plasma membrane localization when fused to heterologous proteins. Nature (London) 314:374–377.
   PubMedGoogle Scholar
• Pellman, D., E. A. Garber, F. R. Cross, and H. Hanafusa. 1985. Fine structural mapping of a critical NH2-terminal region of p60src. Proc. Natl. Acad. Sci. USA 82:1623–1627.
   PubMedGoogle Scholar
• Piwnica-Worms, H., K. B. Saunders, T. M. Roberts, A. E. Smith, and S. H. Cheng. 1987. Tyrosine phosphorylation regulates the biochemical and biological properties of pp60src. Cell 49:75–82.
   PubMed Web of Science ®Google Scholar
• Potts, W. M., A. B. Reynolds, T. J. Lansing, and J. T. Parsons. 1989. Activation of pp60c-src transforming potential by mutations altering the structure of an amino terminal domain containing residues 90-95. Oncogene Res. 3:343–355.
   Google Scholar
• Raymond, V., and J. T. Parsons. 1987. Identification of an amino-terminal domain required for the transforming activity of the Rous sarcoma virus src protein. Virology 160:400–410.
   PubMedGoogle Scholar
• Reynolds, A. B., J. Vila, T. J. Lansing, W. M. Potts, M. J. Weber, and J. T. Parsons. 1987. Activation of the oncogenic potential of the avian cellular src protein by specific structural alteration of the carboxy-terminus. EMBO J. 6:2359–2364.
   PubMed Web of Science ®Google Scholar
• Sadowski, I., J. C. Stone, and T. Pawson. 1986. A noncatalytic domain conserved among cytoplasmic protein-tyrosine kinases modifies the kinase function and transforming activity of Fujinami sarcoma virus P130gag-fps. Mol. Cell. Biol. 6:4396–4408.
   PubMed Web of Science ®Google Scholar
• Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463–5467.
   PubMed Web of Science ®Google Scholar
• Sefton, B. M., I. S. Trowbridge, J. A. Cooper, and E. M. Scolnick. 1982. The transforming proteins of Rous sarcoma virus, Harvey sarcoma virus and Abelson virus contain tightly bound lipid. Cell 31:465–474.
   PubMed Web of Science ®Google Scholar
• Simon, M. A., B. Drees, T. Kornberg, and J. M. Bishop. 1985. The nucleotide sequence and the tissue-specific expression of Drosophila c-src. Cell 42:831–840.
   PubMedGoogle Scholar
• Snyder, M. A., J. M. Bishop, J. P. McGrath, and A. D. Levinson. 1985. A mutation at the ATP-binding site of pp60v-src abolishes kinase activity, transformation, and tumorigenicity. Mol. Cell. Biol. 5:1772–1779.
   PubMedGoogle Scholar
• Stahl, M. L., C. R. Frentz, K. L. Kelleher, R. W. Kritz, and J. L. Knopf. 1988. Sequence similarity of phospholipase C with the non-catalytic region of src. Nature (London) 332:269–272.
   PubMed Web of Science ®Google Scholar
• Temin, H. M., and H. Rubin. 1958. Characteristics of an assay for Rous sarcoma virus and Rous sarcoma cells in tissue culture. Virology 6:669–688.
   PubMed Web of Science ®Google Scholar
• Van Etten, R. A., P. Jackson, and D. Baltimore. 1989. The mouse type IV c-abl gene product is a nuclear protein, and activation of transforming ability is associated with cytoplasmic localization. Cell 58:669–678.
   PubMed Web of Science ®Google Scholar
• Varmus, H. E., N. Quintrell, and J. Wyke. 1981. Revertants of an ASV-transformed rat cell line have lost the complete pro virus or sustained mutations in src. Virology 108:28–46.
   PubMedGoogle Scholar
• Verderame, M. F., J. M. Kaplan, and H. E. Varmus. 1989. A mutation in v-src that removes a single conserved residue in the SH-2 domain of pp60v-src restricts transformation in a hostdependent manner. J. Virol. 63:338–348.
   PubMedGoogle Scholar
• Vogel, U. S., R. A. F. Dixon, M. D. Schaber, R. E. Diehl, M. S. Marshall, E. M. Scolnick, I. S. Sigal, and J. B. Gibbs. 1988. Cloning of bovine GAP and its interaction with oncogenic ras p21. Nature (London) 335:90–93.
   PubMed Web of Science ®Google Scholar
• Wang, H.-C., and J. T. Parsons. 1989. Deletions and insertions within an amino-terminal domain of pp60v-src inactivate transforming and modulate membrane stability. J. Virol. 63:291–302.
   PubMedGoogle Scholar
• Wyke, J. A., and A. W. Stocker. 1987. Genetic analysis of the form and function of the viral src oncogene product. Biochim. Biophys. Acta 907:47–69.
   PubMedGoogle Scholar